# Vitalant – FDA Inspection, Oct 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/63c8f284-f32d-4ac6-8373-c92609a44d81
Source feed: FDA_Inspections

> FDA inspection 1069507 of Vitalant, October 22, 2018. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069507
- Company Name: Vitalant
- Inspection Date: 2018-10-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1143609 - 2021-05-28
- FDA Inspection 1024859 - 2017-08-16
- FDA Inspection 967560 - 2015-10-29
- FDA Inspection 901684 - 2014-10-29
- FDA Inspection 805561 - 2012-11-01

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gloria-a-milster/22f95276-6f68-467d-8d52-5c028c118123)

Company: https://www.keypedia.com/companies/vitalant/b86a560a-90c0-4c98-b94e-a8bd54611bee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d